Objectives: This systematic review aimed to put the case reports of lung cancer on Korean medicine (KM) together and adopt the results in clinical practice. Methods: Researches were searched using the PubMed, EMBASE, OASIS, KoreanTK, KISTI, RISS, KISS, and NDSL. The search term were 'lung cancer' and KM. There was no restriction in year. Results: 1. Among the 48 studies, 68 patients were reported in total. The types of lung cancer were non-small-cell lung cancer (n=41) and small-cell lung cancer (n=6). 2. The number of patients who received KM therapy alone was 40. On the other hand, 25 patients were treated with KM and chemotherapy simultaneously. All case reports used herbal medicine except 2 studies. Other types of treatment were acupuncture, moxibustion, pharmacopuncture, cupping, meditation, etc. 3. Several efficacy evaluation variables were used such as tumor size, changes of symptoms, duration of survival, the quality of life, and so on. The safety was evaluated by checking adverse effects using blood test. 4. Regarding the tumor response, partial response was reported in 12 cases, stable disease was in 22 cases, 50% of the total cases, which is a high level of tumor response. Furthermore, all 11 cases with the evaluation on the length of survival showed prolonged survival than the expectancy of corresponding stage, with the stable quality of life. Conclusion: We have found that the applicability of KM for treatment of lung cancer through this review. Evidence based medicine can be realized by checking cases and applying them in clinical practice.
Introduction
Lung cancer is the major cause of deaths from cancer worldwide, and one of the common types of cancer.
1)
According to the statistics of year 2017 in the United States, lung cancer accounts for 27% and 25% of deaths from cancer in men and women population respectively;
2) the recent research in Korea reported lung cancer is the second most prevalent cancer among men, the fifth among women, and the fourth in total.
The five-year survival rate being 26.7% -the lowest among the top ten cancers, it is one of the fatal types of cancer.
3)
The standard treatment of lung cancer is surgery, radiotherapy, and chemotherapy. The recurrence rate of lung cancer after surgery is relatively high, 4) and more than 50% of lung cancer patients are found with metastasis at the time of diagnosis. This leads to Records identified through National database searching (n = 321)
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Among the 48 studies, 68 patients were reported in total. Except for 5 cases of cancer metastasized to lung (3 cases of primary hepatocellular cancer, 1 case of primary rectal cancer, 1 case of bladder cancer), other studies were primary lung cancer.
The types of lung cancer were non-small-cell lung cancer (NSCLC, n=41) and small-cell lung cancer (SCLC, n=6), with 8 unknown cases (undescribed in 7 cases and biopsy refused in one case). Among NSCLC studies, squamous cell carcinoma was reported in 12 cases, adenocarcinoma in 22 cases, and unknown in 7 cases; SCLC studies included 2 cases of limited stage, 1 case of extensive stage, and 3 unknown cases.
The number of lung cancer patients with a single metastasis were 33 -the sites were the opposite lung (n=7), brain (n=7), lymph nodes (n=9), bone (n=4), pleura (n=6) and unknown in 2 cases. Multiple metastasis was reported in 7 cases: 1 patient to lymph nodes, bones, and chest wall; 1 patient to the brain and bones; 1 patient to the brain and the opposite lung; 2 patients to lymph nodes and the opposite lung; 1 patient to the lymph nodes, the opposite lung, and the body of pancreas. One patient was diagnosed as Mx, so it was described just as mediastinum and pericardial invasion. (Table 1) 4) The types of treatment
The number of patients who received KM therapy alone was 38. The reasons of taking KM therapy alone are to prevent recurrence/metastasis of tumor or to treat side effect after having finished standard western treatment such as surgery, chemotherapy, and radiotherapy; the refusal of patients to receive standard western treatment; and old age.
On the other hand, 25 patients were treated with KM and chemotherapy simultaneously. The chemotherapy drugs were olmutinib, crizotinib, gefitinib, gemcitabine, cisplatin, pemetrexed, erlotinib, bevacizumab, afatinib, paclitaxel, and carboplatin, most of which were target agents. There were 3 cases with the type of chemotherapy undescribed in the paper.
One patient received both chemotherapy and radiotherapy. The western medication used to subside symptoms were narcotic analgesics (oxycodone, fentanyl patch, and codein), antibiotics, steroids (dexamethasone), diuretics (mannitol), mucolytics (erdosteine) and the medication for urinary incontinence (propiverine), for bronchitis (morniflumate), and for psychosis (quetiapine). Other medications were 1 case of SCLC patient with brain metastasis Two cases evaluated metastasized tumor, both of which were about brain metastasis. All the details are provided in the Table 2. (Table 2) (2) Safety evaluation variables
The safety was evaluated by checking adverse effects using blood test (liver and kidney function test mainly)
or N CI-CTCAE. Details are in the table 3.
6) Major results
As a result of evaluating the tumor size, partial response (PR) was in 12 cases -including "decrease" of tumor size, and stable disease (SD) was in 22 cases -including "no interval change." On the other hand, time to progress (TTP), evaluated by the tumor size based on RECIST, was used in one study. The number of studies searched in the international database (PubMed and EMBASE) was fewer than that of articles in the national databases. The reason why case reports on KM are hard to find in the international databases may be related to the phenomenon where the most journals are reluctant to publish case reports because the low citation index of the case report negatively influences the impact factor of the journal.
18)
Regarding the trend of publishing case reports by year, it has been constant since 1997, and especially in 2011, 7 case reports were published at the peak. 
19)
Among the NSCLC patients were 12 cases of squamous cell carcinoma and 22 cases of adenocarcinoma which is dominant; this result corresponds to the steady trend of increasing percentage of squamous cell carcinoma in Korea as long as the north America and Japan.
20)
Meanwhile, SCLC were only in 6 cases, half of which did not describe whether limited or extensive stage.
In consideration of it, SCLC has not been widely dealt with in clinical KM, and further case reports are to be expected to accumulate.
Advanced cancer with metastasis were found in 40 cases, which accounts for 59% of the total. This reflects the characteristic of lung cancer; more than 40% of NSCLC are diagnosed after developing metastasis, which is stage IV, 19) and two thirds of SCLC are found with distant metastasis other than chest wall at the point of diagnosis. 21) Assuming that the case reports are reflection of virtual clinic, the number of advanced lung cancer patients are considerable, and KM treatment reflecting this clinical reality needs to be established.
In clinics, the characteristic of lung cancer to be easily metastasized should be considered when treating patients.
The number of patients under combined standard treatment and KM was 25 in the selected cases reports.
The number of patients under KM therapy alone was 
27)
Experimental studies showed that geonchil induces apoptosis, 28) inhibits tumor cell growth 29) and angiogenesis, 30) 38) and in patients with lung cancer relatively.
39)
The cases analyzed in this study are the instances of applying these experimental research in clinics based on effective results -which is significant in that the experimental studies indeed reach out to clinics for clinical verification. More and more case studies need accumulate to build the evidence of cancer treatment.
Other herbal medicine to improve the patient's symptoms are Bojung-ikki-tang, Maekmundong-tang, Geumsuyukunjun, and so on. These are prescribed to The subjective measurements were changes in symptoms of subjective complaints and the QOL.
Evaluation on the QOL of cancer patients is considered important in treating them and assessing their status along with the survival rate and the tumor response, 41) and there has been plenty of studies on the QOL.
42)
Although specialized questionnaires by type of cancer have been developed, there were only two cases of using such a questionnaire in this study unfortunately. We integrated and analyzed case reports on lung cancer in the society of KM in Korea. For practitioners, it is important to check cases and apply them in clinical (481) practice, and evidence based medicine (EBM) is considered to be the fundamental knowledge and skill of medical profession when making clinical decisions.
17)
EBM is defined as integration of the latest research evidence, clinical experience of the practitioner, and the value of patients. 44) The latest research evidence means patient-centered clinical study, and case reports are considered low level of evidence to apply in studies.
However, under current situation where large-scale randomized controlled trials about KM treatment on lung cancer are scarce, case reports can be alternative to higher level of evidence. Furthermore, the insight into patient, intervention, and outcome drawn from the discussion will make the foundation for well-designed clinical trial suitable for the characteristics of KM treatment.
